E Selzer

Summary

Affiliation: University of Vienna
Country: Austria

Publications

  1. ncbi Erythropoietin receptor expression in human melanoma cells
    E Selzer
    Department of Radiotherapy and Radiobiology, University Hospital, Vienna, Austria
    Melanoma Res 10:421-6. 2000
  2. ncbi Effects of betulinic acid alone and in combination with irradiation in human melanoma cells
    E Selzer
    Department of Radiotherapy and Radiobiology, University Hospital, Vienna, Austria
    J Invest Dermatol 114:935-40. 2000
  3. ncbi Protein kinase C isoforms in normal and transformed cells of the melanocytic lineage
    E Selzer
    Department of Radiotherapy and Radiobiology, University Hospital Vienna, Vienna, Austria
    Melanoma Res 12:201-9. 2002
  4. ncbi Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx
    C M Glaser
    University Clinics for Oral and Maxillofacial Surgery, General Hospital, Vienna, Austria
    Int J Radiat Oncol Biol Phys 50:705-15. 2001
  5. ncbi Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase II trial
    L Vormittag
    Division of Clinical Oncology, Department of Medicine I and Cancer Center, Medical University Vienna, Vienna, Austria
    Strahlenther Onkol 188:235-42. 2012
  6. ncbi Characterization of NVX-207, a novel betulinic acid-derived anti-cancer compound
    M Willmann
    Clinic for Internal Medicine and Infectious Diseases, University of Veterinary Medicine Vienna, Vienna, Austria
    Eur J Clin Invest 39:384-94. 2009
  7. ncbi Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
    D Thurnher
    Department of Otorhinolaryngology, Division of Oncology, University Hospital of Vienna, Vienna, Austria
    Anticancer Drugs 12:205-8. 2001

Collaborators

Detail Information

Publications7

  1. ncbi Erythropoietin receptor expression in human melanoma cells
    E Selzer
    Department of Radiotherapy and Radiobiology, University Hospital, Vienna, Austria
    Melanoma Res 10:421-6. 2000
    ..This observation might be useful in the early diagnosis of melanoma...
  2. ncbi Effects of betulinic acid alone and in combination with irradiation in human melanoma cells
    E Selzer
    Department of Radiotherapy and Radiobiology, University Hospital, Vienna, Austria
    J Invest Dermatol 114:935-40. 2000
    ....
  3. ncbi Protein kinase C isoforms in normal and transformed cells of the melanocytic lineage
    E Selzer
    Department of Radiotherapy and Radiobiology, University Hospital Vienna, Vienna, Austria
    Melanoma Res 12:201-9. 2002
    ....
  4. ncbi Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx
    C M Glaser
    University Clinics for Oral and Maxillofacial Surgery, General Hospital, Vienna, Austria
    Int J Radiat Oncol Biol Phys 50:705-15. 2001
    ....
  5. ncbi Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase II trial
    L Vormittag
    Division of Clinical Oncology, Department of Medicine I and Cancer Center, Medical University Vienna, Vienna, Austria
    Strahlenther Onkol 188:235-42. 2012
    ....
  6. ncbi Characterization of NVX-207, a novel betulinic acid-derived anti-cancer compound
    M Willmann
    Clinic for Internal Medicine and Infectious Diseases, University of Veterinary Medicine Vienna, Vienna, Austria
    Eur J Clin Invest 39:384-94. 2009
    ..We here present a novel semi-synthetic betulinic acid-derived drug candidate well suited for further clinical development...
  7. ncbi Ifosfamide and mitoxantrone in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck
    D Thurnher
    Department of Otorhinolaryngology, Division of Oncology, University Hospital of Vienna, Vienna, Austria
    Anticancer Drugs 12:205-8. 2001
    ..Severe organ toxicity except alopecia (91%) was not observed. Ifosfamide combined with mitoxantrone does not improve the therapeutic armentarium in recurrent squamous cell carcinoma of the head and neck...